News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in Medicine
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Asembia 2025 |
Sales Effectiveness|
Latest Executive Roundtables
Advertisement

Ross Weaver

Advertisement

Articles by Ross Weaver

Open label PQ.png

The Feasibility of Patient Insights Before Launch

ByAarthi Iyer,Ross Weaver
July 16th 2019

Obtaining patient perspectives during open-label extension trials.

Obtaining Patient Perspectives During Open Label Extension Trials

ByAarthi Iyer,Ross Weaver
June 18th 2019

Getting patient insights before launch is more feasible than you might think.

Advertisement

Latest Updated Articles

  • Obtaining Patient Perspectives During Open Label Extension Trials
    Obtaining Patient Perspectives During Open Label Extension Trials

    Published: June 18th 2019 | Updated:

  • Open label PQ.png
    The Feasibility of Patient Insights Before Launch

    Published: July 16th 2019 | Updated:



Advertisement
Advertisement

Trending on PharmExec

1

Novo Nordisk Stock Reacts to Recent Board Changes

2

Bob Mauch: Strengthening the Chain

3

Pharmaceutical Executive Daily: Novo Nordisk's Board Shake-Up

4

Takeda and Innovent Biologics Announce Strategic Global Partnership

5

MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us